NEUROONE MEDICAL TECHNOLOGIES Corp SEC filings NMTC

NEUROONE MEDICAL TECHNOLOGIES Corp has 653 filings in SEC EDGAR's recent list, going back to Oct 4, 2010. Its latest annual report, Form ARS, was filed on Mar 9, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (results of operations, other events). The company's fiscal year ends on September 30.

NEUROONE MEDICAL TECHNOLOGIES Corp SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Other events
Oct 5, 2026 Oct 5, 2026
8-K Current report
Other events
Aug 27, 2026 Aug 27, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
424B5 Prospectus supplement Jun 12, 2026 —
8-K Current report
Other events
Jun 12, 2026 Jun 12, 2026
10-Q/A Amended quarterly report Jun 12, 2026 Mar 31, 2026
SD Specialized disclosure (conflict minerals) May 29, 2026 —
SD Specialized disclosure (conflict minerals) May 29, 2026 —
8-K Current report
Restatement, Regulation FD disclosure
May 22, 2026 May 21, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
8-K Current report
Other events
May 4, 2026 Apr 30, 2026
8-K Current report
Officer or director change
Apr 30, 2026 Apr 24, 2026
8-K Current report
Bylaw or fiscal year change
Apr 14, 2026 Apr 14, 2026
8-K Current report
Officer or director change, Shareholder vote results
Apr 3, 2026 Apr 3, 2026
ARS Annual report to shareholders Mar 9, 2026 Sep 30, 2025
DEF 14A Proxy statement Mar 9, 2026 Apr 3, 2026
PRE 14A Preliminary proxy statement Feb 27, 2026 Apr 3, 2026
8-K Current report
Other events
Feb 25, 2026 Feb 25, 2026
8-K Current report
Results of operations
Feb 17, 2026 Feb 17, 2026
10-Q Quarterly report Feb 17, 2026 Dec 31, 2025
10-K/A Amended annual report Jan 23, 2026 Sep 30, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 22, 2025 Dec 18, 2025
S-8 Employee stock plan registration Dec 19, 2025 —
8-K Current report
Results of operations
Dec 17, 2025 Dec 17, 2025
10-K Annual report Dec 17, 2025 Sep 30, 2025
SD Specialized disclosure (conflict minerals) Dec 16, 2025 —
SD Specialized disclosure (conflict minerals) Dec 16, 2025 —
8-K Current report
Listing notice
Nov 5, 2025 Nov 4, 2025
8-K Current report
Results of operations, Other events
Oct 6, 2025 Oct 6, 2025
8-K Current report
Other events
Aug 18, 2025 Aug 18, 2025
8-K Current report
Other events
Aug 15, 2025 Aug 15, 2025
424B5 Prospectus supplement Aug 15, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 13, 2025 May 13, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Listing notice
May 9, 2025 May 6, 2025
8-K Current report
Material agreement
Apr 7, 2025 Apr 4, 2025
424B5 Prospectus supplement Apr 4, 2025 —
424B5 Prospectus supplement Apr 3, 2025 —
424B5 Prospectus supplement Apr 3, 2025 —
S-8 Employee stock plan registration Feb 21, 2025 —
8-K/A Amended current report
Officer or director change, Shareholder vote results
Feb 20, 2025 Feb 14, 2025
8-K Current report
Shareholder vote results
Feb 14, 2025 Feb 14, 2025
10-Q Quarterly report Feb 12, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 12, 2025 Feb 12, 2025
DEFA14A Additional proxy material Feb 7, 2025 —
DEFA14A Additional proxy material Feb 5, 2025 —
8-K Current report
Other events
Feb 4, 2025 Feb 3, 2025
ARS Annual report to shareholders Jan 21, 2025 Sep 30, 2024
DEF 14A Proxy statement Jan 21, 2025 Feb 14, 2025
8-K Current report
Regulation FD disclosure
Jan 14, 2025 Jan 14, 2025
PRER14A Revised preliminary proxy statement Jan 13, 2025 —
8-K Current report
Listing notice
Jan 10, 2025 Jan 8, 2025
PRE 14A Preliminary proxy statement Jan 10, 2025 Jan 10, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 10, 2025 Jan 10, 2025
8-K Current report
Results of operations, Other events
Dec 17, 2024 Dec 17, 2024
10-K Annual report Dec 17, 2024 Sep 30, 2024
8-K Current report
Agreement ended
Nov 8, 2024 Nov 7, 2024
8-K Current report
Material agreement, Other events
Oct 31, 2024 Oct 25, 2024
EFFECT Filing Sep 13, 2024 —
8-K Current report
Officer or director change
Sep 13, 2024 Sep 9, 2024
CORRESP Letter to the SEC Sep 12, 2024 —
S-3/A Amendment no. 1 to form s-3 Sep 12, 2024 —
UPLOAD Letter from the SEC Sep 5, 2024 —
S-3 Shelf registration Aug 30, 2024 —
EFFECT Filing Aug 16, 2024 —
424B5 Prospectus supplement Aug 16, 2024 —
D Filing Aug 16, 2024 —
CORRESP Letter to the SEC Aug 15, 2024 —
S-3/A Amendment no. 1 to form s-3 Aug 14, 2024 —
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale
Aug 7, 2024 Aug 1, 2024
8-K Current report
Listing notice
Jul 12, 2024 Jul 11, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jun 21, 2024 Jun 20, 2024
UPLOAD Letter from the SEC Jun 7, 2024 —
S-3 Shelf registration May 31, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
8-K Current report
Other events
Mar 26, 2024 Mar 26, 2024
8-K Current report
Shareholder vote results, Regulation FD disclosure
Mar 15, 2024 Mar 14, 2024
8-K Current report
Results of operations
Feb 13, 2024 Feb 13, 2024
10-Q Quarterly report Feb 13, 2024 Dec 31, 2023
S-8 Employee stock plan registration Jan 31, 2024 —
ARS Annual report to shareholders Jan 29, 2024 Sep 30, 2023
DEF 14A Proxy statement Jan 29, 2024 Mar 14, 2024
424B5 Prospectus supplement Jan 5, 2024 —
S-8 Employee stock plan registration Dec 15, 2023 —
10-K Annual report Dec 15, 2023 Sep 30, 2023
8-K Current report
Results of operations
Dec 14, 2023 Dec 14, 2023
8-K Current report
Other events
Dec 11, 2023 Dec 11, 2023
424B5 Prospectus supplement Dec 1, 2023 —
8-K Current report
Other events
Nov 16, 2023 Nov 16, 2023
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Nov 14, 2023 Nov 9, 2023
8-K Current report
Other events
Nov 7, 2023 Nov 7, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Material agreement, Other events
Jul 27, 2023 Jul 24, 2023
424B5 Prospectus supplement Jul 26, 2023 —
424B5 Prospectus supplement Jul 24, 2023 —
424B5 Prospectus supplement Jul 24, 2023 —
10-Q Quarterly report May 12, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Shareholder vote results
Mar 17, 2023 Mar 16, 2023
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
S-8 Employee stock plan registration Feb 22, 2023 —
8-K Current report
Results of operations, Regulation FD disclosure
Feb 14, 2023 Feb 14, 2023
10-Q Quarterly report Feb 13, 2023 Dec 31, 2022
ARS Annual report to shareholders Jan 27, 2023 Sep 30, 2022
DEF 14A Proxy statement Jan 27, 2023 Mar 16, 2023
8-K Current report
Other events
Jan 13, 2023 Jan 9, 2023
8-K Current report
Results of operations
Dec 22, 2022 Dec 22, 2022
424B5 Prospectus supplement Dec 22, 2022 —
10-K Annual report Dec 22, 2022 Sep 30, 2022
8-K Current report Dec 16, 2022 Dec 12, 2022
8-K Current report
Other events
Oct 25, 2022 Oct 25, 2022
8-K Current report
Regulation FD disclosure
Sep 14, 2022 Sep 14, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 3, 2022 Aug 2, 2022
8-K Current report
Shareholder vote results, Other events
Jun 2, 2022 May 31, 2022
10-K/A Amended annual report May 31, 2022 Sep 30, 2021
8-K Current report
Other events
May 16, 2022 May 16, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
DEF 14A Proxy statement Apr 29, 2022 May 31, 2022
8-K Current report
Other events
Mar 25, 2022 Mar 25, 2022
8-K Current report
Results of operations
Feb 14, 2022 Feb 14, 2022
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
8-K Current report
Officer or director change
Feb 4, 2022 Feb 3, 2022
S-8 Employee stock plan registration Jan 28, 2022 —
10-K Annual report Dec 15, 2021 Sep 30, 2021
8-K Current report
Results of operations
Dec 15, 2021 Dec 15, 2021
S-8 Employee stock plan registration Nov 23, 2021 —
8-K Current report
Material agreement, Results of operations, Other events
Oct 14, 2021 Oct 13, 2021
424B5 Prospectus supplement Oct 14, 2021 —
424B5 Prospectus supplement Oct 13, 2021 —
8-K Current report
Other events
Oct 4, 2021 Oct 4, 2021
8-K Current report
Other events
Sep 7, 2021 Sep 7, 2021
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 13, 2021 Aug 13, 2021
8-K Current report
Auditor change
Jun 24, 2021 Jun 18, 2021
EFFECT Filing Jun 14, 2021 —
CORRESP Letter to the SEC Jun 10, 2021 —
UPLOAD Letter from the SEC Jun 9, 2021 —
8-K Current report
Shareholder vote results
Jun 8, 2021 Jun 2, 2021
S-3 Shelf registration Jun 4, 2021 —
8-K Current report
Other events
May 25, 2021 May 25, 2021
CERT Filing May 25, 2021 —
8-A12B Form 8-a12b May 25, 2021 —
10-Q Quarterly report May 14, 2021 Mar 31, 2021
DEF 14A Proxy statement May 6, 2021 Jun 2, 2021
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Mar 31, 2021 Mar 31, 2021
424B3 Prospectus Mar 9, 2021 —
EFFECT Filing Mar 8, 2021 —
CORRESP Letter to the SEC Mar 5, 2021 —
S-1/A Amended registration statement Mar 5, 2021 —
CORRESP Letter to the SEC Mar 4, 2021 —
8-K Current report
Other events
Feb 23, 2021 Feb 23, 2021
UPLOAD Letter from the SEC Feb 19, 2021 —
10-Q Quarterly report Feb 16, 2021 Dec 31, 2020
10-K/A Amended annual report Feb 12, 2021 Sep 30, 2020
S-1 Registration statement Feb 10, 2021 —
10-K/A Amended annual report Jan 28, 2021 Sep 30, 2020
D Filing Jan 27, 2021 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 15, 2021 Jan 12, 2021
8-K Current report
Officer or director change
Jan 7, 2021 Jan 1, 2021
10-K Annual report Dec 9, 2020 Sep 30, 2020
424B3 Prospectus Oct 9, 2020 —
8-K Current report
Other events
Oct 6, 2020 Oct 6, 2020
EFFECT Filing Oct 2, 2020 —
POS AM Post-effective amendment no. 1 to form s-1 Sep 30, 2020 —
424B3 Prospectus Sep 8, 2020 —
8-K Current report
Unregistered share sale
Sep 3, 2020 Aug 31, 2020
EFFECT Filing Aug 28, 2020 —
CORRESP Letter to the SEC Aug 27, 2020 —
S-1/A Amended registration statement Aug 27, 2020 —
UPLOAD Letter from the SEC Aug 20, 2020 —
10-Q Quarterly report Aug 13, 2020 Jun 30, 2020
S-1 Registration statement Aug 12, 2020 —
D Filing Aug 10, 2020 —
8-K Current report
Material agreement, Unregistered share sale
Aug 3, 2020 Jul 28, 2020
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 28, 2020 Jul 23, 2020
8-K Current report
Material agreement, Other events
Jul 22, 2020 Jul 20, 2020
8-K Current report
Material agreement, New debt, Unregistered share sale
Jul 2, 2020 Jun 26, 2020
8-K Current report
Material agreement, New debt, Unregistered share sale, Shareholder vote results
Jun 4, 2020 May 29, 2020
10-Q Quarterly report May 14, 2020 Mar 31, 2020
D Filing May 14, 2020 —
8-K Current report
Material agreement, New debt, Unregistered share sale
May 12, 2020 May 8, 2020
8-K Current report
Material agreement, New debt, Unregistered share sale
May 1, 2020 Apr 30, 2020
DEF 14A Proxy statement May 1, 2020 Jun 2, 2020
8-K Current report
Material agreement, New debt, Unregistered share sale
Apr 30, 2020 Apr 24, 2020
PRE 14A Preliminary proxy statement Apr 16, 2020 Jun 2, 2020
8-K Current report
Regulation FD disclosure
Apr 6, 2020 Apr 6, 2020
8-K Current report
Unregistered share sale, Officer or director change
Feb 24, 2020 Feb 18, 2020
10-Q Quarterly report Feb 14, 2020 Dec 31, 2019
10-K/A Amended annual report Jan 28, 2020 Sep 30, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
NMTC (Nasdaq)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
Eden Prairie, MN
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1500198
Former names
Original Source Entertainment, Inc. (until May 22, 2017)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.